WESTLAKE CORP WLK
NYSE · XNYS · stock · Industrial Organic Chemicals
Chart by TradingView
3/9
Piotroski F — financial health
2.89
Altman Z″ — distress risk · safe
-18.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $11.2B | -$1.5B | $813.0M | -$530.0M | $8.8B |
| 2024 | $12.1B | $602.0M | $2.0B | $306.0M | $11.0B |
| 2023 | $12.5B | $479.0M | $2.2B | $1.3B | $10.8B |
| 2022 | $15.8B | $2.2B | $4.1B | $2.3B | $10.5B |
| 2021 | $11.8B | $2.0B | $3.5B | $1.7B | $8.5B |
| 2020 | $7.5B | $330.0M | $1.0B | $772.0M | $6.6B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Bender Mark Steven | EVP & CFO | 2026-05-13 | Tax withheld | 5,284 | $97.34 |
| Bender Mark Steven | EVP & CFO | 2026-05-12 | Option exercise | 13,164 | — |
| Buesinger Robert F. | EVP, PEM Segment Head | 2026-03-27 | Sell | 4,000 | $115.25 |
| Bender Mark Steven | EVP & CFO | 2026-03-27 | Sell | 16,413 | $112.53 |
| Bender Mark Steven | EVP & CFO | 2026-02-27 | Sell | 421 | $101.52 |
| Bender Mark Steven | EVP & CFO | 2026-02-27 | Disposition | 12,693 | $98.20 |
| Bender Mark Steven | EVP & CFO | 2026-02-27 | Option exercise | 6,199 | $65.81 |
| Bender Mark Steven | EVP & CFO | 2026-02-27 | Option exercise | 6,494 | $86.54 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.89 (safe)
- Working capital / assets 0.173
- Retained earnings / assets 0.436
- EBIT / assets -0.079
- Equity / liabilities 0.824
Source: SEC EDGAR filings · CIK 0001262823 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.